All Resources

AAO24: Allergic Rhinitis: Avoidance of Leukotriene Inhibitors

AAO24: Allergic Rhinitis: Avoidance of Leukotriene Inhibitors

Download PDF

High Priority: Yes; Appropriate Use
Percentage of patients age 2 years and older patients with allergic rhinitis who do not receive leukotriene inhibitors.

Denominator:
All patients age 2 years and older with allergic rhinitis with a diagnosis of allergic rhinitis who do not have an active order
(prescription or reported over the counter use) of intranasal corticosteroids or second generation antihistamines.

Denominator Exclusions:
Exclude patients with concomitant diagnosis of asthma or sleep apnea.

Denominator Exceptions:
Patients with allergy to intranasal corticosteroids, allergy to second generation antihistamines, or prostate issues (due to
concern for intolerance of primary therapy options).

Numerator:
Patients who do not receive leukotriene inhibitors.

Measure Classifications:

  • Measure Type: Process
  • National Quality Strategy (NQS) domain: Effective Clinical Care
  • Meaningful Measure Area: Medication Management
  • Calculation: 1st Performance Rate
    • Inverse measure: No
    • Continuous measure: No
    • Proportional measure: Yes
    • Ratio measure: No
    • Risk Adjusted measure: No
No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.